Gefitrust 250mg Tablet
  1. Home
  2. Pharma Products
  3. Panacea Biotec Ltd
  4. Gefitrust 250mg Tablet

Gefitrust 250mg Tablet

Gefitrust 250 mg Tablet contains gefitinib, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It works by blocking epidermal growth factor receptor tyrosine kinase signals that can support cancer cell growth. The tablet is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Gefitrust 250 mg Tablet is manufactured by Panacea Biotec Ltd and contains 250 mg of gefitinib. It is indicated for adults with locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations. The recommended dose of gefitinib is one 250 mg tablet once daily, and it may be taken with or without food. Treatment should be initiated and monitored by a physician experienced in anticancer therapy.

Technical Specification

Specification Details
Active Ingredient Gefitinib 250 mg
Dosage Form Tablet
Therapeutic Class Tyrosine Kinase Inhibitor
Main Indication Non-Small Cell Lung Cancer
Route of Administration Oral
Recommended Dose 250 mg Once Daily

Product Also Known As

Gefitrust 250 mg, Gefitrust Gefitinib 250 mg Tablet, Gefitinib 250 mg Tablet, Gefitinib Oncology Tablet, Gefitinib Lung Cancer Tablet, Gefitinib EGFR Inhibitor Tablet